Role of nitric oxide signaling in endothelial differentiation of embryonic stem cells

Stem Cells and Development

Volumn 19, Issue 10, 2010, Pages 1617-1625

  Huang, Ngan F ^a   Fleissner, Felix ^a   Sun, John ^a   Cooke, John P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MATRIGEL; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CYCLIC GMP; EMBRYONIC STEM CELLS; ENDOTHELIAL CELLS; ENZYME INHIBITORS; MICE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SIGNAL TRANSDUCTION;

MURINAE;

EID: 77957557090     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2009.0417     Document Type: Article

References (32)

1. Thomson JA, J Itskovitz-Eldor, SS Shapiro, MA Waknitz, JJ Swiergiel, VS Marshall and JM Jones. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147.
2. Reubinoff BE, MF Pera, CY Fong, A Trounson and A Bongso. (2000). Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro. Nat Biotechnol 18:399-404.
3. Behfar A, LV Zingman, DM Hodgson, JM Rauzier, GC Kane, A Terzic and M Pucéat. (2002). Stem cell differentiation requires a paracrine pathway in the heart. FASEB J 16:1558-1566.
4. Levenberg S, JS Golub, M Amit, J Itskovitz-Eldor and R Langer. (2002). Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 99:4391-4396.
5. Yamashita J, H Itoh, M Hirashima, M Ogawa, S Nishikawa, T Yurugi, M Naito, K Nakao and S Nishikawa. (2000). Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408:92-96.
6. Yang L, MH Soonpaa, ED Adler, TK Roepke, SJ Kattman, M Kennedy, E Henckaerts, K Bonham, GW Abbott, RM Linden, LJ Field and GM Keller. (2008). Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell- derived population. Nature 453:524-528.
7. Moncada S and A Higgs. (1993). The L-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012.
8. Boerrigter G and JC Burnett Jr. (2009). Soluble guanylate cyclase: not a dull enzyme. Circulation 119:2752-2754.
9. Mujoo K, VG Sharin, NS Bryan, JS Krumenacker, C Sloan, S Par veen, LE Nikonoff, AY Kots and F Murad. (2008). Role of nitric oxide signaling components in differentiation of embryonic stem cells into myocardial cells. Proc Natl Acad Sci USA 105:18924-18929.
10. Mujoo K, JS Krumenacker, Y Wada and F Murad. (2006). Differential expression of nitric oxide signaling components in undifferentiated and differentiated human embryonic stem cells. Stem Cells Dev 15:779-787
11. Krumenacker JS, S Katsuki, A Kots and F Murad. (2006). Differential expression of genes involved in cGMP-dependent nitric oxide signaling in murine embryonic stem (ES) cells and ES cell-derived cardiomyocytes. Nitric Oxide 14:1-11.
12. Danalache BA, J Paquin, W Donghao, R Grygorczyk, JC Moore, CL Mummery, J Gutkowska and M Jankowski. (2007). Nitric oxide signaling in oxytocin-mediated cardiomyogenesis. Stem Cells 25:679-688.
13. Lee TC, YD Zhao, DW Courtman and DJ Stewart. (2000). Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase. Circulation 101:2345-2348.
14. Feng Q, W Song, X Lu., JA Hamilton, M Lei, T Peng and SP Yee. (2002). Development of heart failure and congenital septal defects in mice lacking endothelial nitric oxide synthase. Circulation 106:873-879.
15. Niebauer J, J Dulak, JR Chan, PS Tsao and JP Cooke. (1999). Gene transfer of nitric oxide synthase: effects on endothelial biology. J Am Coll Cardiol 34:1201-1207
16. Dulak J, A Józkowicz, A Dembinska-Kiec, I Guevara, A Zdzienicka, D Zmudzinska-Grochot, I Florek, A Wojtowicz, A Szuba and JP Cooke. (2000). Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 20:659-666.
17. Jacobi J, K Sydow, G Von Degenfeld, Y Zhang, H Dayoub, B Wang, AJ Patterson, M Kimoto, HM Blau and JP Cooke. (2005). Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis. Circulation 111:1431-1438.
18. Cao F, K.E. Van Der Bogt, A Sadrzadeh, X Xie, AY Sheikh, H Wang, AJ Connolly, RC Robbins and JC Wu. (2007). Spatial and temporal kinetics of teratoma formation from murine embryonic stem cell transplantation. Stem Cells Dev 16:883-891.
19. Shetzline SE, R Rallapalli, KJ Dowd, S Zou, Y Nakata, CR Swider, A Kalota, JK Choi and AM Gewirtz. (2004). Neuromedin U: a Myb-regulated autocrine growth factor for human myeloid leukemias. Blood 104:1833-1840.
20. Livak KJ and TD Schmittgen. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
21. Huang NF, S Patel, RG Thakar, J Wu, BS Hsiao, B Chu, RJ Lee and S Li. (2006). Myotube assembly on nanofibrous and micropatterned polymers. Nano Lett 6:537-542.
22. Caiado F, C Real, T Carvalho and S Dias. (2008). Notch pathway modulation on bone marrow-derived vascular precursor cells regulates their angiogenic and wound healing potential. PLoS ONE 3:e3752.
23. Budworth J, S Meillerais, I Charles and K Powell. (1999). Tissue distribution of the human soluble guanylate cyclases. Biochem Biophys Res Commun 263:696-701.
24. Bryan NS, K Bian and F Murad. (2009). Discovery of the nitric oxide signaling pathway and targets for drug development. Front Biosci 14:1-18.
25. Cooke JP. (2003). Flow, NO, and atherogenesis. Proc Natl Acad Sci USA 100:768-770.
26. Jang JJ, HK Ho, HH Kwan, LF Fajardo and JP Cooke. (2000). Angiogenesis is impaired by hypercholesterolemia: role of asymmetric dimethylarginine. Circulation 102:1414-1419.
27. Papapetropoulos A, G García-Cardeña, JA Madri and WC Sessa. (1997). Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 100:3131-3139.
28. Cooke JP. (2004). Asymmetrical dimethylarginine: the Über marker? Circulation 109:1813-1818.
29. Lin KY, A Ito, T Asagami, PS Tsao, S Adimoolam, M Kimoto, H Tsuji, GM Reaven and JP Cooke. (2002). Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation 106:987-992.
30. Böger R.H., SM Bode-Böger, A Szuba, PS Tsao, JR Chan, O Tangphao, TF Blaschke and JP Cooke. (1998). Asymmetrie dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 98:1842-1847.
31. Morishita T, M Tsutsui, H Shimokawa, K Sabanai, H Tasaki, O Suda, S Nakata, A Tanimoto, KY Wang, Y Ueta, Y Sasaguri, Y Nakashima and N Yanagihara. (2005). Nephrogenic diabetes insipidus in mice lacking all nitric oxide synthase isoforms. Proc Natl Acad Sci USA 102:10616-10621.
32. Bloch W, BK Fleischmann, DE Lorke, C Andressen, B Hops, J Hescheler and K Addicks. (1999). Nitric oxide synthase expression and role during cardiomyogenesis. Cardiovasc Res 43:675-684.